2009

1. LONG-TERM FOLLOW UP OF THE EFFECTIVENESS OF STANDARD DOSE BCG (81 MG. CONNAUGHT STRAIN) COMPARING WITH A THREE FOLD REDUCE DOSE (27 MG.) IN HIGH RISK NON MUSCLE INVASIVE BLADDER CANCER. CUETO GROUP

   EUROPEAN UROLOGY SUPPLEMENTS